Literature DB >> 17718806

Interleukin-6 and tumour necrosis factor in synovial fluid from horses with carpal joint pathology.

C Ley1, S Ekman, A Elmén, G Nilsson, M-L Eloranta.   

Abstract

The carpal joints are common sites of traumatic arthritis and osteoarthritis (OA) in athletic horses. The pro-inflammatory cytokines interleukin (IL)-6 and tumour necrosis factor (TNF) may be of great importance in the development of intra-articular lesions. The aim of the present study was to investigate possible associations between synovial fluid levels of bioactive IL-6 and TNF and different types of joint lesions seen in traumatic arthritis and OA. Synovial fluid was collected from horses with carpal lameness immediately before arthroscopic surgery. Articular cartilage, synovial membranes and intra-articular ligaments were assessed macroscopically at arthroscopy. Synovial fluid levels of IL-6 and TNF were determined by bioassays, and the cytokine levels between different grades of morphologic changes in each type of assessed tissue were compared. The highest levels of IL-6 were detected in joints with chip fractures. All joints with chip fractures also showed some degree of synovitis. Tumour necrosis factor bioactivity was low and not associated with any joint lesion. Hence, TNF is not useful as a biomarker indicating a specific joint lesion in equine traumatic arthritis or OA. We conclude that a dramatic increase of IL-6 in synovial fluid indicates the presence of osteochondral fragmentation, although low or undetectable levels of IL-6 do not exclude chip fractures. The role of IL-6 in the disease process of osteochondral fragmentation needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17718806     DOI: 10.1111/j.1439-0442.2007.00956.x

Source DB:  PubMed          Journal:  J Vet Med A Physiol Pathol Clin Med        ISSN: 0931-184X


  8 in total

Review 1.  Cytokines as biochemical markers for knee osteoarthritis.

Authors:  Thomas Mabey; Sittisak Honsawek
Journal:  World J Orthop       Date:  2015-01-18

2.  Altered protein levels in bone marrow lesions of hip osteoarthritis: Analysis by proteomics and multiplex immunoassays.

Authors:  Maziar Shabestari; Yashar R Shabestari; Maria A Landin; Milaim Pepaj; Timothy P Cleland; Janne E Reseland; Erik F Eriksen
Journal:  Int J Rheum Dis       Date:  2020-05-07       Impact factor: 2.454

3.  Anticytokine therapy for osteoarthritis: evidence to date.

Authors:  Charles J Malemud
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

4.  The Effect of Different Types of Musculoskeletal Injuries on Blood Concentration of Serum Amyloid A in Thoroughbred Racehorses.

Authors:  Agnieszka Turło; Anna Cywińska; Michał Czopowicz; Lucjan Witkowski; Artur Niedźwiedź; Malwina Słowikowska; Hieronim Borowicz; Anna Jaśkiewicz; Anna Winnicka
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

5.  Autologous processed plasma: cytokine profile and effects upon injection into healthy equine joints.

Authors:  Juliana J Moreira; Ana Paula L Moraes; Patrícia M Brossi; Thaís S L Machado; Yara M Michelacci; Cristina O Massoco; Raquel Y A Baccarin
Journal:  J Vet Sci       Date:  2014-09-30       Impact factor: 1.672

6.  Pro-inflammatory cytokines and structural biomarkers are effective to categorize osteoarthritis phenotype and progression in Standardbred racehorses over five years of racing career.

Authors:  Andrea Bertuglia; Eleonora Pagliara; Elena Grego; Alessandro Ricci; Nika Brkljaca-Bottegaro
Journal:  BMC Vet Res       Date:  2016-11-08       Impact factor: 2.741

7.  Comparison of the Effects of Interleukin-1 on Equine Articular Cartilage Explants and Cocultures of Osteochondral and Synovial Explants.

Authors:  Christopher R Byron; Richard A Trahan
Journal:  Front Vet Sci       Date:  2017-09-20

8.  Early OA Stage Like Response Occurs after Dynamic Stretching of Human Synovial Fibroblasts.

Authors:  Ute Nazet; Susanne Grässel; Jonathan Jantsch; Peter Proff; Agnes Schröder; Christian Kirschneck
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.